사이토소브런츠(CTSO)는 NASDAQ에 상장된 Healthcare · Medical Devices 기업입니다. 현재가 $0.40 (+10.38%), 시가총액 $0.03B, 52주 범위 $0.48 ~ $1.29.
Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform in the United States, Germany, and internationally. Its flagship product, CytoSorb, is an extracorporeal blood purification cartridge to reduce cytokine storms in common critical illnesses, bilirubin in liver failure, myoglobin in trauma and critical illnesses, and inflammatory mediators and blood thinners in cardiac surgery applications, as well as to remove antithrombotic drugs and inflammatory mediators in cardiothoracic surgery applications. The company also develops DrugSorb-ATR antithrombotic removal system, an investigational device to
사이토소브런츠의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 BlackQuant에서 실시간으로 확인할 수 있습니다.
사이토소브런츠의 현재 주가는 $0.40 (+10.38%)입니다. BlackQuant에서 실시간 시세와 차트를 확인할 수 있습니다.
사이토소브런츠의 시가총액은 약 $0.03B입니다.
Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform in the United States, Germany, and international